“The US must act now to leverage rapidly increasing US domestic vaccine production, export ever-larger volumes of our surplus supplies, and go to work on the massive technical and logistical challenges to vaccine development on a global scale,” the letter said.
The group also expressed opposition to the intellectual property waiver being promoted by the World Trade Organization, saying the move “would make little difference and could do harm” by not considering the steps necessary for safely manufacturing the vaccines.
The letter, initiated by C.V. Starr & Co. chairman and chief executive officer Maurice R. Greenberg, noted that the world
